SCHEMBL6826209

SCHEMBL6826209

CC(CCC(C)N1CCC(NC(=O)c2ccc(Cl)c(Cl)c2)CC1)Oc1cccc2c1C(=O)C(C)(C)O2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 2/20 0.46
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTR7 P34969 1/20 0.39
UTS2R Q9UKP6 12/20 0.38
ACHE P22303 1/20 0.38
CHRNA7 P36544 1/20 0.37
HTR1A P08908 1/20 0.37
CYP2D6 P10635 1/20 0.37
DRD2 P14416 1/20 0.37
HTR1D P28221 1/20 0.37
HTR2C P28335 1/20 0.37
HTR1F P30939 1/20 0.37
HTR2B P41595 1/20 0.37
HTR6 P50406 1/20 0.37
CYP3A43 Q9HB55 1/20 0.37
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6823918 0.90 PTK2 (0.47) PTK2ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL6823920 0.89 PTK2 (0.45) PTK2MEN1KMT2AHTR7UTS2R
SCHEMBL6824418 0.84 HTR7 (0.40) PTK2MEN1KMT2AHTR7UTS2R
SCHEMBL6824544 0.83 HTR7 (0.40) PTK2MEN1KMT2AHTR7UTS2R
SCHEMBL6826210 0.82 PTK2 (0.44) PTK2HTR7UTS2RHTR1ACYP2D6
SCHEMBL6820544 0.81 UTS2R (0.38) PTK2MEN1KMT2AHTR7UTS2R
SCHEMBL6820571 0.80 PTK2 (0.49) PTK2HTR7UTS2RHTR1ADRD2
SCHEMBL6824127 0.74 HTR7 (0.45) PTK2HTR7UTS2RACHEHTR1A
SCHEMBL6824129 0.73 HTR7 (0.43) MEN1KMT2AHTR7UTS2RHTR1A
SCHEMBL6824422 0.67 HTR7 (0.42) HTR7UTS2RHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004076444-A2 NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC F. HOFFMANN-LA ROCHE AG (CH) 2004-09-10 WO claimed
WO-2004076444-A2 NOVEL HYDROXYCOUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC F. HOFFMANN-LA ROCHE AG (CH) 2004-09-10 WO disclosed